Zepbound: First Approved Treatment for Sleep Apnea in Obese Adults Zepbound is now the first FDA-approved medication for treating moderate-to-severe obstructive sleep apnea in adults with obesity, offering new hope for sufferers.
Breakthrough Drug Reduces Sleep Apnea Symptoms Discover a groundbreaking drug that's five times more effective than a placebo in treating sleep apnea, with 50% of patients experiencing complete relief.